{"id":10835,"date":"2018-01-26T19:06:40","date_gmt":"2018-01-26T19:06:40","guid":{"rendered":"http:\/\/drupal.test\/projects\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/"},"modified":"2022-07-26T10:57:54","modified_gmt":"2022-07-26T14:57:54","slug":"elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des","status":"publish","type":"project","link":"https:\/\/dev.genomecanada.ca\/fr\/project\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/","title":{"rendered":"\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients"},"content":{"rendered":"<p>Les cancers lympho\u00efdes, qui commencent dans le syst\u00e8me immunitaire et qui comprennent les lymphomes hodgkiniens et non hodgkiniens, les my\u00e9lomes et la leuc\u00e9mie lymphoblastique font partie des cinq cancers les plus courants chez les hommes et les femmes et touchent des personnes de tous \u00e2ges. Tous les ans au Canada, 16\u00a0000\u00a0personnes re\u00e7oivent un diagnostic de cancer lympho\u00efde et 6\u00a0000 d\u2019entre elles en meurent. Le d\u00e9c\u00e8s survient le plus souvent lorsque la maladie r\u00e9cidive apr\u00e8s un traitement initial fructueux, ce qui rend le traitement et la ma\u00eetrise des sympt\u00f4mes de la r\u00e9cidive de la maladie des besoins les plus pressants pour les patients atteints de ces formes de cancers.<\/p>\n<p>Comme on ne conna\u00eet pas les causes de la r\u00e9cidive et parce que les r\u00e9cidives de cancer diff\u00e8rent consid\u00e9rablement du cancer initial, il n\u2019existe pas de tests cliniques pour renseigner sur le pronostic de chacun des patients et les r\u00e9sultats possibles des traitements, ni de tests pour orienter les m\u00e9decins et les patients sur l\u2019utilisation d\u2019autres th\u00e9rapies, par exemple les m\u00e9dicaments de petites mol\u00e9cules ou l\u2019immunoth\u00e9rapie. Les r\u00e9cidives et les traitements connexes co\u00fbtent au syst\u00e8me de sant\u00e9 canadien plus de 315\u00a0millions de dollars par ann\u00e9e, soit environ 10\u00a0% du budget pr\u00e9vu en m\u00e9dicaments anticanc\u00e9reux en\u00a02022; l\u2019absence de tests cliniques signifie \u00e9galement qu\u2019un grand nombre de ces traitements co\u00fbteux sont utilis\u00e9s sans orientation suffisante.<\/p>\n<p>Les D<sup>rs<\/sup> Christian Steidl, Marco Marra et David Scott du BC Cancer Research Centre \u00e9laborent des tests cliniques fond\u00e9s sur la g\u00e9nomique pour am\u00e9liorer les r\u00e9sultats pour les patients et leur qualit\u00e9 de vie, et travaillent \u00e0 l\u2019int\u00e9gration de ces tests dans le syst\u00e8me de sant\u00e9. Pour ce faire, l\u2019\u00e9quipe s\u00e9quencera des tumeurs de r\u00e9cidives afin d\u2019identifier de nouveaux biomarqueurs. Elle proc\u00e9dera \u00e0 des analyses \u00e9conomiques pour\u00a0 mieux comprendre le rapport co\u00fbt-efficacit\u00e9 et les r\u00e9percussions sur le syst\u00e8me de sant\u00e9 de la gestion fond\u00e9e sur la g\u00e9nomique des r\u00e9cidives de la maladie. Elle \u00e9laborera \u00e9galement une application de cybersant\u00e9 pour aider les patients \u00e0 participer \u00e0 la prise de d\u00e9cision.<\/p>\n<p>Les r\u00e9sultats de ce projet seront de nouveaux tests cliniques qui soutiendront les d\u00e9cisions des m\u00e9decins et des patients, aideront les d\u00e9cideurs \u00e0 mettre en \u0153uvre les approches des traitements personnalis\u00e9s dans le cas des r\u00e9cidives de cancer lympho\u00efde et r\u00e9duiront les co\u00fbts du traitement des r\u00e9cidives de cancer lympho\u00efde.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les cancers lympho\u00efdes, qui commencent dans le syst\u00e8me immunitaire et qui comprennent les lymphomes hodgkiniens et non hodgkiniens, les my\u00e9lomes et la leuc\u00e9mie lymphoblastique font partie des cinq cancers les plus courants chez les hommes et les femmes et touchent des personnes de tous \u00e2ges. Tous les ans au Canada, 16\u00a0000\u00a0personnes re\u00e7oivent un diagnostic de [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[93],"genome-competitions":[213],"project-sector":[],"genome_centres":[105],"class_list":["post-10835","project","type-project","status-publish","hentry","project-categories-large-scale-science-fr","genome-competitions-concours-2017-projets-de-recherche-appliquee-a-grande-echelle-la-genomique-et-la-sante-de-precision","genome_centres-genome-british-columbia-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Les cancers lympho\u00efdes, qui commencent dans le syst\u00e8me immunitaire et qui comprennent les lymphomes hodgkiniens et non hodgkiniens, les my\u00e9lomes et la leuc\u00e9mie lymphoblastique font partie des cinq cancers les plus courants chez les hommes et les femmes et touchent des personnes de tous \u00e2ges. Tous les ans au Canada, 16\u00a0000\u00a0personnes re\u00e7oivent un diagnostic de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.genomecanada.ca\/fr\/project\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T14:57:54+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\\\/\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\\\/\",\"name\":\"\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2018-01-26T19:06:40+00:00\",\"dateModified\":\"2022-07-26T14:57:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/dev.genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients - GenomeCanada","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients - GenomeCanada","og_description":"Les cancers lympho\u00efdes, qui commencent dans le syst\u00e8me immunitaire et qui comprennent les lymphomes hodgkiniens et non hodgkiniens, les my\u00e9lomes et la leuc\u00e9mie lymphoblastique font partie des cinq cancers les plus courants chez les hommes et les femmes et touchent des personnes de tous \u00e2ges. Tous les ans au Canada, 16\u00a0000\u00a0personnes re\u00e7oivent un diagnostic de [&hellip;]","og_url":"https:\/\/dev.genomecanada.ca\/fr\/project\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T14:57:54+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/","url":"https:\/\/dev.genomecanada.ca\/fr\/project\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/","name":"\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients - GenomeCanada","isPartOf":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#website"},"datePublished":"2018-01-26T19:06:40+00:00","dateModified":"2022-07-26T14:57:54+00:00","breadcrumb":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.genomecanada.ca\/fr\/project\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/elucider-la-biologie-genomique-des-recidives-de-cancer-lymphoide-pour-ameliorer-la-gestion-des\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"\u00c9lucider la biologie g\u00e9nomique des r\u00e9cidives de cancer lympho\u00efde pour am\u00e9liorer la gestion des patients"}]},{"@type":"WebSite","@id":"https:\/\/dev.genomecanada.ca\/fr\/#website","url":"https:\/\/dev.genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/dev.genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/dev.genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/dev.genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/dev.genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/dev.genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10835\/revisions"}],"wp:attachment":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=10835"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=10835"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=10835"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=10835"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=10835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}